ReD worked with Cognizant, taking an outside-in perspective to study the phenomenon of healing.

We interview Lufthansa’s Andrew Muirhead to talk about innovation in airlines and what flights will be like in the future.

Understanding cultural differences is good for drug companies’ top lines, and also for pushing the boundaries of medical science.

With the new reality of pharmaceutical R&D, companies must deliver impact and value. This paper explores how ethnographic research can fill that role in early stages of pharmaceutical clinical trials.

How understanding the social, psychological, and emotional experience of psoriasis is fueling the pharmaceutical industry.

ReD facilitated Coloplast’s transition to compliance with a more micro-level approach to innovation.

ReD conducted Novo Nordisk’s first study around the emotional experience of patients living with diabetes.

Airport design is becoming less monumental and architecturally ego-driven, and more user-friendly.